[1] Yokoo T, Kamimura K, Abe H, et al. Liver-targeted hydrodynamic gene therapy: Recent advances in the technique. World J Gastroenterol. 2016;22(40):8862-8868.[2] Uchida K, Nakajima H, Guerrero AR, et al. Gene therapy strategies for the treatment of spinal cord injury. Ther Deliv. 2014;5(5):591-607.[3] Gao M, Liu D. Gene therapy for obesity: progress and prospects. Discov Med. 2014;17(96):319-328.[4] Miao YL, Wu W, Li BW, et al. Clinical effectiveness of gene therapy on critical limb ischemia: a meta-analysis of 5 randomized controlled clinical trials. Vasc Endovascular Surg. 2014;48(5-6):372-377. [5] Loukogeorgakis SP, Flake AW. In utero stem cell and gene therapy: current status and future perspectives. Eur J Pediatr Surg. 2014;24(3):237-245.[6] Nagel-Wolfrum K, Möller F, Penner I, et al. Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations. Vis Neurosci. 2014;31(4-5):309-316.[7] Yang X, Tietje AH, Yu X, et al. Mouse interleukin-12/FasTI: A novel bi-functional fusion protein for cancer immuno/gene therapy. Int J Oncol. 2016;48(6):2381-2386.[8] Hernandez-Alcoceba R, Poutou J, Ballesteros-Briones MC, et al. Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12. Immunotherapy. 2016; 8(2):179-198.[9] Razi Soofiyani S, Kazemi T, Lotfipour F, et al. Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model. Artif Cells Nanomed Biotechnol. 2016;44(8):1988-1993.[10] Luo M, Liang X, Luo ST, et al. Folate-Modified Lipoplexes Delivering the Interleukin-12 Gene for Targeting Colon Cancer Immunogene Therapy. J Biomed Nanotechnol. 2015;11(11): 2011-2023.[11] Aizman I, Tirumalashetty BJ, McGrogan M, et al. Comparison of the neuropoietic activity of gene-modified versus parental mesenchymal stromal cells and the identification of soluble and extracellular matrix-related neuropoietic mediators. Stem Cell Res Ther. 2014;5(1):29.[12] 任义德,张亚峰,尤武林,等.Foxc2基因修饰骨髓间充质干细胞修复实验性兔股骨头坏死[J].中国组织工程研究,2016,20(6):834- 840. [13] Li Y, Zheng L, Xu X, et al. Mesenchymal stem cells modified with angiopoietin-1 gene promote wound healing. Stem Cell Res Ther. 2013;4(5):113.[14] Nong Y, Zhang C, Wei L, et al. In situ investigation of allografted mouse HCN4 gene-transfected rat bone marrow mesenchymal stromal cells with the use of patch-clamp recording of ventricular slices. Cytotherapy. 2013;15(8): 905-919.[15] 崔利德,李铁民.碱性成纤维细胞生长因子基因修饰骨髓间充质干细胞移植修复急性肾损伤[J].中国组织工程研究,2016, 20(28):4169-4175. [16] 洪澜,李成学,贺国丽,等.卵巢癌生物治疗的现状与进展[J].现代生物医学进展,2016,16(6):1180-1183. [17] 许辉茹,冯慧晶,张俊萍,等.卵巢癌生物治疗新进展[J].国际肿瘤学杂志,2013,40(11):861-864.[18] Parhar RS, Zou M, Al-Mohanna FA, et al. IL-12 immunotherapy of Braf(V600E)-induced papillary thyroid cancer in a mouse model. Lab Invest. 2016;96(1):89-97.[19] Li X, Zhang P, Liu X, et al. Expression of interleukin-12 by adipose-derived mesenchymal stem cells for treatment of lung adenocarcinoma. Thorac Cancer. 2015;6(1):80-84.[20] Jarosz-Biej M, Smolarczyk R, Cichoń T, et al. Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice. Arch Immunol Ther Exp (Warsz). 2015;63(6):451-464.[21] Zhang L, Morgan RA, Beane JD, et al. Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma. Clin Cancer Res. 2015;21(10):2278-2288.[22] Cutrera J, King G, Jones P, et al. Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro- chemo-gene therapy. J Cell Mol Med. 2015;19(3):664-675.[23] Cutrera J, King G, Jones P, et al. Safety and efficacy of tumor-targeted interleukin 12 gene therapy in treated and non-treated, metastatic lesions. Curr Gene Ther. 2015;15(1): 44-54.[24] Ahmed Ali HA, Di J, Mei W, et al. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro. Asian Pac J Cancer Prev. 2014;15(2):611-616.[25] 赵雯红,程建新,黄军岩,等.白细胞介素-12基因修饰人脐带间充质干细胞抗裸鼠移植瘤的作用[J].中华实验外科杂志,2011, 28(5):798-800. [26] 王久香,康柏会,司宁宁,等.转染白细胞介素-12基因的脐带间充质干细胞对胃腺癌细胞的影响[J].广东医学,2015,36(13):1987- 1990. [27] Bao Q, Zhao Y, Niess H, et al. Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer. Stem Cells Dev. 2012;21(13):2355-2363.[28] Hu J, Li H, Chi G, et al. IL-1RA gene-transfected bone marrow-derived mesenchymal stem cells in APA microcapsules could alleviate rheumatoid arthritis. Int J Clin Exp Med. 2015;8(1):706-713.[29] Wang L, Zhao Y, Cao J, et al. Mesenchymal stem cells modified with nerve growth factor improve recovery of the inferior alveolar nerve after mandibular distraction osteogenesis in rabbits. Br J Oral Maxillofac Surg. 2015; 53(3):279-284.[30] Han ZM, Huang HM, Wang FF. Brain-derived neurotrophic factor gene-modified bone marrow mesenchymal stem cells. Exp Ther Med. 2015;9(2):519-522.[31] 鲁先闯,张志峰,黄健,等.骨髓间充质干细胞修复软骨缺损的应用前景[J].中国组织工程研究,2015,19(19):3083-3088. [32] Frisch J, Venkatesan JK, Rey-Rico A, et al. Determination of the chondrogenic differentiation processes in human bone marrow-derived mesenchymal stem cells genetically modified to overexpress transforming growth factor-β via recombinant adeno-associated viral vectors. Hum Gene Ther. 2014;25(12): 1050-1060.[33] Pan Q, Qin X, Ma S, et al. Myocardial protective effect of extracellular superoxide dismutase gene modified bone marrow mesenchymal stromal cells on infarcted mice hearts. Theranostics. 2014;4(5):475-486.[34] 张秋艳,熊艳,叶啟发,等.骨髓间充质干细胞修复肝脏缺血-再灌注损伤研究进展[J].中华实验外科杂志,2016,33(3):871-874.[35] 娄典.体外扩增临床应用骨髓间充质干细胞的研究进展[J].医学综述,2013,19(10):1748-1751.[36] 白东,周忠笑,张健,等.人端粒酶反转录酶基因修饰骨髓间充质干细胞调控肝细胞增殖和凋亡[J].中国组织工程研究,2015, 19(32):5118-5122. [37] 宋燕峰,曹洁.碱性成纤维细胞生长因子转染骨髓间充质干细胞移植治疗肺动脉高压[J].中国组织工程研究,2015,19(6): 918- 922. [38] Wang A, Zhou X, Zhao J, et al. Therapeutic effects of bone marrow mesenchymal stem cells expressing interleukin-12 in mice bearing malignant ascites tumor. Int J Clin Exp Med. 2015;8(9):15840-15845.[39] Wang A, Zhou X, Zhao J,et al.Therapeutic effects of bone marrow mesenchymal stem cells expressing interleukin-12 in mice bearing malignant ascites tumor. Int J Clin Exp Med. 2015;8(9):15840-15845.[40] Li X, Zhang P, Liu X, et al. Expression of interleukin-12 by adipose-derived mesenchymal stem cells for treatment of lung adenocarcinoma. Thorac Cancer. 2015;6(1):80-84.[41] Jeong KY, Lee EJ, Kim SJ, et al. Irradiation-induced localization of IL-12-expressing mesenchymal stem cells to enhance the curative effect in murine metastatic hepatoma. Int J Cancer. 2015;137(3):721-730.[42] Han J, Zhao J, Xu J, et al. Mesenchymal stem cells genetically modified by lentivirus-mediated interleukin-12 inhibit malignant ascites in mice. Exp Ther Med. 2014;8(4): 1330-1334. |